Depicting real-life treatment journeys for patients affected with an immune-inflammatory condition and treated with methotrexate

Study identification

• EU PAS number:
  EUPAS1000000159
• Study ID:
  1000000159
• Official title and acronym:
  Depicting real-life treatment journeys for patients affected with an immune-inflammatory condition and treated with methotrexate
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  No information provided.
• Study status:
  Ongoing

Study timelines

Date when funding contract was signed

Planned:27/04/2023

Actual:27/04/2023

Study start date

Actual:27/04/2023

Date of final study report

Planned:30/09/2026

Sources of funding

Other

Pharmaceutical company and other private sector 

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable